Skip to content
DataLookout
Menu

NCT07078682

An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 9 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

Version history last read from ClinicalTrials.gov on Aug 31, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Jan 2026 to Nov 2026
    • Enrollment closed, study ongoing
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    • Study title shortened, about 1 word
    v2
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Change in uterine fibroid-related symptom severity
Timeframe: Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24

Secondary (1)

Change in fibroid-related health-related quality of life domains

Arms and interventions

Elix Cycle Balance & Elix Daily HarmonyExperimental

Participants will receive two investigational herbal supplements daily for 24 weeks.

Dietary supplements: Elix Daily Harmony

Sites

1 site in 1 country

  • CitruslabsLas Vegas, Nevada, United States